David Méndez-Luna

Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations

David Méndez-Luna, Marlet Martínez‐Archundia, Rachid C. Maroun et al. · Journal of Biomolecular Structure and Dynamics · 2015 · 73 citations

The effects of (−)-epicatechin on endothelial cells involve the G protein-coupled estrogen receptor (GPER)

Aldo Moreno‐Ulloa, David Méndez-Luna, Ernesto Beltrán‐Partida et al. · Pharmacological Research · 2015 · 67 citations · Full text

Endothelial Cell Pathobiology, Molecular Pharmacology, Signal Transduction +13

Antihyperglycemic activity of the leaves from <i>Annona cherimola</i> miller and rutin on alloxan-induced diabetic rats

Fernando Calzada, Jesús Iván Solares-Pascasio, Rosa María Ordóñez‐Razo et al. · Pharmacognosy Research · 2017 · 52 citations · Full text

N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed <i>in silico</i> with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells

Berenice Prestegui-Martel, Jorge Antonio Bermúdez-Lugo, Alma Chávez‐Blanco et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2016 · 42 citations · Full text

Understanding the molecular basis of agonist/antagonist mechanism of GPER1/GPR30 through structural and energetic analyses

David Méndez-Luna, Martiniano Bello, José Correa‐Basurto · The Journal of Steroid Biochemistry and Molecular Biology · 2016 · 34 citations

Molecular Pharmacology, Biochemistry, Functional Selectivity +10